US Physicalrapy Financials
USPH Stock | USD 98.02 0.19 0.19% |
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Debt Equity Ratio | 0.47 | 0.3821 |
|
| |||||
Current Ratio | 2.17 | 2.2838 |
|
|
The essential information of the day-to-day investment outlook for US Physicalrapy includes many different criteria found on its balance sheet. An individual investor should monitor US Physicalrapy's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in US Physicalrapy.
Net Income |
|
USPH | Select Account or Indicator |
Understanding current and past US Physicalrapy Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of US Physicalrapy's financial statements are interrelated, with each one affecting the others. For example, an increase in US Physicalrapy's assets may result in an increase in income on the income statement.
US Physicalrapy Stock Summary
US Physicalrapy competes with Acadia Healthcare, Tenet Healthcare, HCA Holdings, DaVita HealthCare, and InnovAge Holding. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The company was founded in 1990 and is based in Houston, Texas. US Physical operates under Medical Care Facilities classification in the United States and is traded on New York Stock Exchange. It employs 3158 people.Specialization | Health Care, Health Care Equipment & Services |
Instrument | USA Stock View All |
Exchange | New York Stock Exchange |
ISIN | US90337L1089 |
CUSIP | 90337L108 |
Location | Texas; U.S.A |
Business Address | 1300 West Sam |
Sector | Health Care Providers & Services |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.usph.com |
Phone | 713 297 7000 |
Currency | USD - US Dollar |
US Physicalrapy Key Financial Ratios
Return On Equity | 0.0475 | ||||
Profit Margin | 0.04 % | ||||
Operating Margin | 0.11 % | ||||
Price To Sales | 2.31 X | ||||
Revenue | 604.8 M |
US Physicalrapy Key Balance Sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 560.8M | 594.4M | 749.4M | 858.2M | 997.2M | 1.0B | |
Other Current Liab | 30.9M | 26.5M | 12.5M | 3.4M | 18.7M | 11.7M | |
Net Debt | 114.3M | 78.1M | 194.5M | 263.7M | 105.8M | 111.1M | |
Retained Earnings | 184.4M | 212.0M | 223.6M | 232.9M | 223.8M | 235.0M | |
Accounts Payable | 2.5M | 1.3M | 6.5M | 6.5M | 3.9M | 4.1M | |
Cash | 23.5M | 32.9M | 28.6M | 31.6M | 152.8M | 160.5M | |
Net Receivables | 56.1M | 41.9M | 46.3M | 51.9M | 51.9M | 27.3M | |
Other Current Assets | 5.8M | 12.8M | 20.3M | 27.7M | 28.7M | 30.1M | |
Total Liab | 181.4M | 184.4M | 297.0M | 373.6M | 345M | 362.3M | |
Total Current Assets | 85.4M | 87.6M | 95.2M | 111.3M | 233.4M | 245.0M | |
Short Term Debt | 27.2M | 59.9M | 61.8M | 75.3M | 78.2M | 82.1M | |
Intangible Assets | 52.6M | 56.3M | 86.4M | 108.8M | 109.7M | 115.2M | |
Good Will | 317.7M | 345.6M | 434.7M | 494.1M | 509.6M | 484.1M | |
Common Stock | 149K | 150K | 151K | 152K | 172K | 147.0K | |
Other Assets | 1.5M | 14.1M | 1.6M | 1.6M | 1.9M | 2.1M | |
Long Term Debt | 50.4M | 16.6M | 117.6M | 175.8M | 139.0M | 145.9M | |
Other Liab | 10.2M | 12.3M | 21.7M | 34.3M | 39.5M | 41.5M | |
Net Tangible Assets | 7.7M | 6.6M | (225.5M) | (287.1M) | (258.4M) | (245.4M) | |
Long Term Debt Total | 38.4M | 50.4M | 16.6M | 117.6M | 135.2M | 142.0M |
US Physicalrapy Key Income Statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Interest Expense | 2.1M | 1.6M | 942K | 5.8M | 9.3M | 9.8M | |
Total Revenue | 482.0M | 423.0M | 495.0M | 553.1M | 604.8M | 635.0M | |
Gross Profit | 112.5M | 94.5M | 117.2M | 112.0M | 112.0M | 117.6M | |
Operating Income | 67.4M | 52.4M | 76.8M | 56.8M | 69.6M | 73.0M | |
Ebit | 67.4M | 67.1M | 74.1M | 61.4M | 58.7M | 31.5M | |
Ebitda | 83.1M | 77.7M | 85.7M | 76.1M | 74.4M | 37.7M | |
Cost Of Revenue | 369.5M | 328.5M | 377.8M | 441.1M | 492.8M | 517.5M | |
Net Income | 57.3M | 52.5M | 57.9M | 43.4M | 14.7M | 15.6M | |
Income Tax Expense | 13.6M | 13.0M | 15.3M | 12.2M | 12.2M | 7.7M | |
Income Before Tax | 70.9M | 65.5M | 73.2M | 55.6M | 49.4M | 31.9M | |
Minority Interest | 17.2M | 17.3M | (17.1M) | (11.2M) | (20.4M) | (19.3M) | |
Interest Income | 46K | 142K | 199K | 859K | 3.1M | 3.2M | |
Net Interest Income | (2.0M) | (1.5M) | (743K) | (4.9M) | (6.5M) | (6.8M) |
US Physicalrapy Key Cash Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Change In Cash | 180K | 9.4M | (4.4M) | 3.0M | 121.2M | 127.3M | |
Free Cash Flow | 52.3M | 92.4M | 68.2M | 50.3M | 72.7M | 76.3M | |
Other Non Cash Items | (560K) | 5.7M | 5.1M | 10.2M | 22.3M | 23.4M | |
Capital Expenditures | 10.2M | 7.6M | 8.2M | 8.2M | 9.3M | 5.3M | |
Net Income | 57.3M | 52.5M | 57.9M | 43.4M | 37.2M | 20.1M | |
End Period Cash Flow | 23.5M | 32.9M | 28.6M | 31.6M | 152.8M | 160.5M | |
Depreciation | 10.1M | 10.5M | 11.6M | 14.7M | 15.7M | 16.5M | |
Change To Inventory | (742K) | 4.2M | (12.4M) | (4.7M) | (5.4M) | (5.6M) | |
Dividends Paid | 14.6M | 4.1M | 18.8M | 21.3M | 24.1M | 25.3M | |
Investments | (221K) | (111K) | 427K | (81.3M) | (80.0M) | (76.0M) | |
Change Receivables | (4.5M) | (8.9M) | 2.6M | (11.0M) | (9.9M) | (9.4M) | |
Net Borrowings | 6.6M | (31.0M) | 93.1M | 64.2M | 73.8M | 77.5M | |
Change To Netincome | 16.6M | 14.4M | 35.7M | 33.1M | 38.0M | 39.9M |
USPH Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining US Physicalrapy's current stock value. Our valuation model uses many indicators to compare US Physicalrapy value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across US Physicalrapy competition to find correlations between indicators driving US Physicalrapy's intrinsic value. More Info.US Physicalrapy is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers reporting about 0.89 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for US Physicalrapy is roughly 1.12 . As of now, US Physicalrapy's Return On Equity is increasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the US Physicalrapy's earnings, one of the primary drivers of an investment's value.US Physicalrapy Systematic Risk
US Physicalrapy's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. US Physicalrapy volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twelve with a total number of output elements of fourty-nine. The Beta measures systematic risk based on how returns on US Physicalrapy correlated with the market. If Beta is less than 0 US Physicalrapy generally moves in the opposite direction as compared to the market. If US Physicalrapy Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one US Physicalrapy is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of US Physicalrapy is generally in the same direction as the market. If Beta > 1 US Physicalrapy moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in US Physicalrapy Stock are looking for potential investment opportunities by analyzing not only static indicators but also various US Physicalrapy's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of US Physicalrapy growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
US Physicalrapy November 26, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of US Physicalrapy help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of US Physicalrapy. We use our internally-developed statistical techniques to arrive at the intrinsic value of US Physicalrapy based on widely used predictive technical indicators. In general, we focus on analyzing USPH Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build US Physicalrapy's daily price indicators and compare them against related drivers.
Downside Deviation | 1.44 | |||
Information Ratio | 0.0666 | |||
Maximum Drawdown | 20.31 | |||
Value At Risk | (2.56) | |||
Potential Upside | 3.36 |
Complementary Tools for USPH Stock analysis
When running US Physicalrapy's price analysis, check to measure US Physicalrapy's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy US Physicalrapy is operating at the current time. Most of US Physicalrapy's value examination focuses on studying past and present price action to predict the probability of US Physicalrapy's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move US Physicalrapy's price. Additionally, you may evaluate how the addition of US Physicalrapy to your portfolios can decrease your overall portfolio volatility.
Transaction History View history of all your transactions and understand their impact on performance | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |